GENOMIC PREDICTOR OF RESPONSE AND SURVIVAL FOLLOWING TAXANE-ANTHRACYCLINE CHEMOTHERAPY FOR INVASIVE BREAST CANCER

CONTEXT: Accurate prediction of who will (or won’t) have high probability of survival benefit from standard treatments is fundamental for individualized cancer treatment strategies. OBJECTIVE: To develop a predictor of response and survival from chemotherapy for newly diagnosed invasive breast cance...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JAMA
Egile Nagusiak: Hatzis, Christos, Pusztai, Lajos, Valero, Vicente, Booser, Daniel J., Esserman, Laura, Lluch, Ana, Vidaurre, Tatiana, Holmes, Frankie, Souchon, Eduardo, Martin, Miguel, Cotrina, José, Gomez, Henry, Hubbard, Rebekah, Chacón, J. Ignacio, Ferrer-Lozano, Jaime, Dyer, Richard, Buxton, Meredith, Gong, Yun, Wu, Yun, Ibrahim, Nuhad, Andreopoulou, Eleni, Ueno, Naoto T., Hunt, Kelly, Yang, Wei, Nazario, Arlene, DeMichele, Angela, O’Shaughnessy, Joyce, Hortobagyi, Gabriel N., Symmans, W. Fraser
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5638042/
https://ncbi.nlm.nih.gov/pubmed/21558518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2011.593
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak